
November 5, 2026
from 8h00
until 9h00
Online
INESSS’s Innovation Services Offering: The Role of Evaluation and Access to Innovations in the Quebec Network
Webinar
For all
INESSS’s Innovation Services Offering: The Role of Evaluation and Access to Innovations in the Quebec Network
This webinar will help innovators, entrepreneurs, and partners in the life sciences ecosystem better understand INESSS’s role in evaluating innovations within Quebec’s health and social services network. Participants will learn about the tools and approaches developed by INESSS to assess the value of innovations, support their prioritization, and inform decision-making throughout their lifecycle. Concrete examples of work carried out in the areas of digital technologies, medical devices, and other non-pharmaceutical innovations will be presented, along with an overview of the information and data that can support evaluation processes. The webinar will also address the main pathways and mechanisms that contribute to the adoption of innovations within Quebec’s public healthcare system.
Our
speaker
Mélanie Martin
Deputy Director of Technological Innovation, Medical Biology, and Genomics at INESSS
Mélanie Martin is the Assistant Director of Technological Innovation, Medical Biology, and Genomics at INESSS, where she has worked since 2015 after starting there as a scientific professional. Throughout her career, she has developed strong expertise in health technology assessment, particularly in methodological development and support for evidence-based decision-making. She holds a Ph.D. in microbiology and immunology, as well as additional training in strategic project management and pharmaceutical development from Laval University.
Lyes Bachatene
Health Sciences Professional at INESSS
Lyes Bachatene has been a health science professional at INESSS since 2022. He joined the Drug and Technology Assessment Division for Reimbursement Purposes, where his work focuses on various health-related topics, including drugs, digital technologies, and artificial intelligence. He holds a Ph.D. in neurophysiology of the visual system, has completed postdoctoral training in medical imaging, and has experience in clinical research in dermatology.














